Video

08/12/2023 19:55 (UTC)

US HEALTH

FDA approves first gene-editing technology treatment in the US

Boston (US), Dec 8 (EFE).- The U.S. Food and Drug Administration (FDA) announced on Friday the approval of two treatments for sickle cell disease (SCD), one of which is the first commercially available treatment in the country based on gene-editing technology.

FOOTAGE: VERTEX PHARMACEUTICALS HEADQUARTERS IN BOSTON, MASSACHUSETTS, US.

Camera: CJ Gunther.

Product Suggestions

Photo
EFE Photo
Video
EFE VÍDEO
Text
EFE International News
Stories
Reportajes general América
Photo
Gráfico general y gráfico territorial EUA-Caribe.
Photo
Gráfico general América
Text
EFECOM Internacional
Multimedia
Contenidos digitales general multimedia América